The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) study: Rationale and design

American Heart Journal

Volumn 160, Issue 1, 2010, Pages 42-48

  Burri, Haran ^a   Quesada, Aurelio ^b   Ricci, Renato Pietro ^c   Boriani, Giuseppe ^d   Davinelli, Mario ^e   Favale, Stefano ^f   Da Costa, Antoine ^g   Kautzner, Josef ^h   Moser, Raymond ⁱ   Navarro, Xavier ^j   Santini, Massimo ^c  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Medtronic Italia   (Italy)

^f POLICLINICO   (Italy)

^g UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^h INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

ⁱ Medtronic Schweiz   (Switzerland)

^j Medtronic Iberica SA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; FOLLOW UP; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; LUNG FLUID; MAJOR CLINICAL STUDY; MONITORING; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STANDARD; STUDY DESIGN;

ATRIAL FIBRILLATION; AUTOMATION; DEFIBRILLATORS, IMPLANTABLE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MONITORING, PHYSIOLOGIC; PROSPECTIVE STUDIES; TELEMETRY; TREATMENT OUTCOME;

EID: 77955701309     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.04.005     Document Type: Article

References (21)

1. Dickstein K., Cohen-Solal A., and Filippatos G. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
2. Abraham W.T., Fisher W.G., and Smith A.L. Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
3. Bristow M.R., Saxon L.A., and Boehmer J. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
4. Cleland J.G., Daubert J.C., and Erdmann E. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 2006 1928 1932
5. Yu C.M., Wang L., and Chau E. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization Circulation 112 2005 841 848
6. Abraham W.T. Superior performance of intrathoracic impedance-derived fluid index versus daily weight monitoring in heart failure patients: results of the Fluid Accumulation Status Trial (FAST) Heart Failure Society of America Scientific 2009 Meeting (Boston, MA. Late Breaking Clinical Trials I.) 2009
7. Maines M., Catanzariti D., and Cemin C. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case-control study J Interv Card Electrophysiol 19 2007 201 207
8. Purerfellner H., Gillis A.M., and Holbrook R. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies Pacing Clin Electrophysiol 27 2004 983 992
9. Glotzer T.V., Hellkamp A.S., and Zimmerman J. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST) Circulation 107 2003 1614 1619
10. Swerdlow C.D., Schsls W., and Dijkman B. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators Circulation 101 2000 878 885
11. Capucci A., Santini M., and Padeletti L. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers J Am Coll Cardiol 46 2005 1913 1920
12. Ricci R.P., Morichelli L., and Santini M. Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation Europace 11 2009 54 61
13. Ricci R.P., Morichelli L., and Gargaro A. Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through Monte Carlo simulations J Cardiovasc Electrophysiol 2009
14. Burri H., and Senouf D. Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators Europace 11 2009 701 709
15. Fuster V., Ryden L.E., and Cannom D.S. ACC/AHA/ESC 2006 Guidelines For The Management of Patients With Atrial Fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace 8 2006 651 745
16. Varma N. Lumax-T/Lumos-T safely RedUceS rouTine office device follow-up American Heart Association Annual Scientific Sessions 2008(November 11, 2008; New Orleans, LA. New Trials in Electrophysiology and Pacing) 2008
17. Wilkoff B.L., Auricchio A., and Brugada J. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association Europace 10 2008 707 725
18. Al-Khatib S.M., Piccini J.P., and Knight D. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial J Cardiovasc Electrophysiol 2009 (Epub ahead of print)
19. Raatikainen M.J., Uusimaa P., and van Ginneken M.M. Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up Europace 10 2008 1145 1151
20. Crossley G., Boyle A., and Vitense H. Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study Am Heart J 156 2008 840 846
21. Crossley G.H. The Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial American College of Cardiology Annual Scientific Sessions 2010;March 13 2010, Atlanta(Late Breaking Clinical Trials) 2010